Brief: GenOway Sets Up JV In Shanghai

genOway SA

17/10/2023 17:15

Oct 17 (Reuters) - Genoway SA  ALGEN.PA :
    * SETS UP A JOINT VENTURE IN SHANGHAI WITH THE AIM OF
BECOMING THE
BENCHMARK PARTNER FOR PRECLINICAL RESEARCH IN CHINA
    * WILL HOLD 45% OF THE CAPITAL AND WILL HAVE VETO RIGHTS
OVER THE
JOINT VENTURE'S STRATEGIC CHOICES
    * JOINT VENTURE'S CHINESE PARTNERS WILL BRING THEIR
KNOWLEDGE OF
THE LOCAL MARKET, THEIR NETWORK AND THEIR ABILITY TO RECRUIT AND
LEAD HIGH-LEVEL SCIENTIFIC SALES TEAMS

Source text for Eikon:  ID:nACT82381 
Further company coverage:  ALGEN.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))